When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Technology
·
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
CN
CitrixNews Staff
Originally reported by TechCrunch. Read the full story at the original source.
Related Articles
Technology
Anthropic Is Still at Odds With the White House Over Claude Fable 5
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyTrump administration officials concluded tal...
CitrixNews Staff
·
1 hour ago
Technology
Sundar Pichai faces boos, walkout at Stanford graduation ceremony over Google’s Israel, ICE ties
Over the weekend, Google CEO Sundar Pichai faced a small revolt when he delivered his commencement speech at Stanford Un...
CitrixNews Staff
·
2 hours ago
Technology
Key mission for Europe's commercial space enterprise scrubbed again
Isar Aerospace is not hurting for money, but it is sorely lacking in the currency of flight experience.
CitrixNews Staff
·
2 hours ago
Technology
Xbox is reportedly closing Ninja Theory, Double Fine and Compulsion Games
Gaming Xbox Xbox is reportedly closing Ninja Theory, Double Fine and Compulsion Games Studio leaders are trying to...
CitrixNews Staff
·
2 hours ago